These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
339 related articles for article (PubMed ID: 37091854)
21. Activation of the leukotriene B4 receptor 2-reactive oxygen species (BLT2-ROS) cascade following detachment confers anoikis resistance in prostate cancer cells. Lee JW; Kim JH J Biol Chem; 2013 Oct; 288(42):30054-30063. PubMed ID: 23986446 [TBL] [Abstract][Full Text] [Related]
22. Understanding the cell survival mechanism of anoikis-resistant cancer cells during different steps of metastasis. Khan SU; Fatima K; Malik F Clin Exp Metastasis; 2022 Oct; 39(5):715-726. PubMed ID: 35829806 [TBL] [Abstract][Full Text] [Related]
23. The Prognosis of Cancer Depends on the Interplay of Autophagy, Apoptosis, and Anoikis within the Tumor Microenvironment. Gulia S; Chandra P; Das A Cell Biochem Biophys; 2023 Dec; 81(4):621-658. PubMed ID: 37787970 [TBL] [Abstract][Full Text] [Related]
24. First trimester human placenta prevents breast cancer cell attachment to the matrix: The role of extracellular matrix. Epstein Shochet G; Drucker L; Pomeranz M; Fishman A; Pasmanik-Chor M; Tartakover-Matalon S; Lishner M Mol Carcinog; 2017 Jan; 56(1):62-74. PubMed ID: 26859229 [TBL] [Abstract][Full Text] [Related]
25. Anoikis is regulated by BCL-2-independent pathways in human prostate carcinoma cells. Bondar VM; McConkey DJ Prostate; 2002 Apr; 51(1):42-9. PubMed ID: 11920957 [TBL] [Abstract][Full Text] [Related]
26. Novel targeting of apoptosis pathways for prostate cancer therapy. Garrison JB; Kyprianou N Curr Cancer Drug Targets; 2004 Feb; 4(1):85-95. PubMed ID: 14965270 [TBL] [Abstract][Full Text] [Related]
27. Androgens modify therapeutic response to cabazitaxel in models of advanced prostate cancer. Begemann D; Wang Y; Yang W; Kyprianou N Prostate; 2020 Sep; 80(12):926-937. PubMed ID: 32542812 [TBL] [Abstract][Full Text] [Related]
28. Prostate tumor neuroendocrine differentiation via EMT: The road less traveled. Dicken H; Hensley PJ; Kyprianou N Asian J Urol; 2019 Jan; 6(1):82-90. PubMed ID: 30775251 [TBL] [Abstract][Full Text] [Related]
29. Acquisition of anoikis resistance promotes alterations in the Ras/ERK and PI3K/Akt signaling pathways and matrix remodeling in endothelial cells. de Sousa Mesquita AP; de Araújo Lopes S; Pernambuco Filho PCA; Nader HB; Lopes CC Apoptosis; 2017 Sep; 22(9):1116-1137. PubMed ID: 28653224 [TBL] [Abstract][Full Text] [Related]
30. Epithelial mesenchymal transition is required for acquisition of anoikis resistance and metastatic potential in adenoid cystic carcinoma. Jia J; Zhang W; Liu JY; Chen G; Liu H; Zhong HY; Liu B; Cai Y; Zhang JL; Zhao YF PLoS One; 2012; 7(12):e51549. PubMed ID: 23272116 [TBL] [Abstract][Full Text] [Related]
31. Talin1 promotes tumor invasion and metastasis via focal adhesion signaling and anoikis resistance. Sakamoto S; McCann RO; Dhir R; Kyprianou N Cancer Res; 2010 Mar; 70(5):1885-95. PubMed ID: 20160039 [TBL] [Abstract][Full Text] [Related]
32. Anoikis in prostate cancer bone metastasis gene signatures and therapeutic implications. Xia W; Ye M; Jiang B; Xu G; Xiao G; Zeng Q; Huang R Front Oncol; 2024; 14():1446894. PubMed ID: 39391236 [TBL] [Abstract][Full Text] [Related]
33. Nuclear localization of parathyroid hormone-related peptide confers resistance to anoikis in prostate cancer cells. Park SI; McCauley LK Endocr Relat Cancer; 2012 Jun; 19(3):243-54. PubMed ID: 22291434 [TBL] [Abstract][Full Text] [Related]
34. Critical role for Fas-associated death domain-like interleukin-1-converting enzyme-like inhibitory protein in anoikis resistance and distant tumor formation. Mawji IA; Simpson CD; Hurren R; Gronda M; Williams MA; Filmus J; Jonkman J; Da Costa RS; Wilson BC; Thomas MP; Reed JC; Glinsky GV; Schimmer AD J Natl Cancer Inst; 2007 May; 99(10):811-22. PubMed ID: 17505076 [TBL] [Abstract][Full Text] [Related]
35. TGF-β receptor I inhibitor enhances response to enzalutamide in a pre-clinical model of advanced prostate cancer. Paller C; Pu H; Begemann DE; Wade CA; Hensley PJ; Kyprianou N Prostate; 2019 Jan; 79(1):31-43. PubMed ID: 30155899 [TBL] [Abstract][Full Text] [Related]
36. Collapsin response mediator protein-1 (CRMP1) acts as an invasion and metastasis suppressor of prostate cancer via its suppression of epithelial-mesenchymal transition and remodeling of actin cytoskeleton organization. Cai G; Wu D; Wang Z; Xu Z; Wong KB; Ng CF; Chan FL; Yu S Oncogene; 2017 Jan; 36(4):546-558. PubMed ID: 27321179 [TBL] [Abstract][Full Text] [Related]
37. Novel pharmacologic targeting of tight junctions and focal adhesions in prostate cancer cells. Hensley PJ; Desiniotis A; Wang C; Stromberg A; Chen CS; Kyprianou N PLoS One; 2014; 9(1):e86238. PubMed ID: 24497940 [TBL] [Abstract][Full Text] [Related]
38. Epithelial-mesenchymal-transition regulators in prostate cancer: Androgens and beyond. Nakazawa M; Kyprianou N J Steroid Biochem Mol Biol; 2017 Feb; 166():84-90. PubMed ID: 27189666 [TBL] [Abstract][Full Text] [Related]
39. Mechanisms for Modulating Anoikis Resistance in Cancer and the Relevance of Metabolic Reprogramming. Adeshakin FO; Adeshakin AO; Afolabi LO; Yan D; Zhang G; Wan X Front Oncol; 2021; 11():626577. PubMed ID: 33854965 [TBL] [Abstract][Full Text] [Related]
40. ATF4/CEMIP/PKCα promotes anoikis resistance by enhancing protective autophagy in prostate cancer cells. Yu Y; Liu B; Li X; Lu D; Yang L; Chen L; Li Y; Cheng L; Lv F; Zhang P; Song Y; Xing Y Cell Death Dis; 2022 Jan; 13(1):46. PubMed ID: 35013120 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]